Weight Loss Drugs in Cardiology: A Game Changer? 💊❤️ [h0na3__P0PF]
Weight Loss Drugs in Cardiology: A Game Changer? 💊❤️ [h0na3__P0PF]
| 1h 28m 28s | Video has closed captioning.
Weight Loss Drugs in Cardiology: A Game Changer? 💊❤️ As a cardiologist, I often get asked about medications like Ozempic, Wegovy, Mounjaro, and Zepbound. These aren’t just “weight loss drugs”—they’re revolutionizing how we approach heart health. Here’s why they matter: 1️⃣ For Patients with Diabetes: These medications lower blood sugar and help reduce cardiovascular risks. They’re a double win for patients with diabetes who are at higher risk of heart attacks and strokes. 2️⃣ For Patients Without Diabetes: Even if you don’t have diabetes, these drugs can support weight loss, which reduces the strain on your heart, lowers blood pressure, and improves cholesterol levels—key for primary prevention of heart disease. 3️⃣ For Patients with Heart Failure: Heart failure is often worsened by excess weight. These medications help reduce fluid retention, improve exercise tolerance, and may improve long-term outcomes in certain types of heart failure. 4️⃣ For Blood Pressure and Cholesterol: Weight loss itself improves these critical markers, making these drugs essential tools for patients with obesity-related hypertension or high cholesterol. 5️⃣ For Overall Heart Protection: Reducing obesity helps reverse metabolic syndrome, a major contributor to heart attacks, strokes, and sudden cardiac death. 💡 Bottom line: These medications go beyond the scale—they can be life-saving for the heart. Always consult with your doctor to see if they’re right for you. #HeartHealth #Cardiology #WeightLossJourney #Ozempic #Wegovy #Mounjaro #Zepbound #gummy keto weight loss #luke combs keto acv gummies #keto gummies in nz #purefit keto pills
Aired: January 07, 2025
Buy Now:
Problems Playing Video? | Closed Captioning